This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property (No.3) Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kemal Payza: Innovator in Pharmaceutical Development
Introduction
Kemal Payza is an accomplished inventor based in Laval, Canada. He is currently associated with GlaxoSmithKline Intellectual Property Limited, where he contributes to the field of pharmaceutical development. Although he has not yet been granted any patents, his work is significant in advancing medical science.
Latest Patent Applications
Kemal Payza's notable patent application is titled "Crystalline Forms of a Substituted Imidazopyridine Compound and Use Thereof as P2X3 Modulator." This application describes crystalline forms of a P2X3 modulator, specifically (S)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl-7-methylimidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate or a solvate thereof. The application outlines the use of this compound for treating various conditions, including pain, urinary tract disorders, cough, pruritus, and endometriosis.
Conclusion
Kemal Payza is a promising inventor whose work in pharmaceutical innovation holds potential for significant medical advancements. His contributions, particularly in the area of P2X3 modulators, reflect his commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile